A blood-based metabolomics test to distinguish relapsing–remitting and secondary progressive multiple sclerosis: addressing practical considerations for clinical application (Scientific Reports, 2020)

(untitled) - Yeo, T; Sealey, M; Zhou, Y; Saldana, L; Loveless, S; Claridge, TDW; Robertson, N; DeLuca, G; Palace, J; Anthony, DC; Probert, F